Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer
NCT03828838
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Prostate Neoplasm
Interventions
DRUG:
Lu-177 PSMA-617
Sponsor
Radboud University Medical Center